Desktop Scanners
PRODUCTS
-
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
-
The PBS-80 Vertical Wheel bioreactor is the ultimate tool for large-scale manufacturing of therapeutic cells. With the currently largest available working volume of 80L, the PBS-80 can handle commercial manufacturing of cell therapy products.
-
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
An excellent alternative to traveling wave tube amplifiers, Qorvo’s Spatium™ QPB0618N is a solid state, spatial combining amplifier with an operating range of 6–18 GHz.
-
The all-rounder, star of the show plug-and play isolator.
The soloVERSO™ isolator meets the needs of various applications in the pharmaceutical manufacturing process. Upgrade your existing plant to handle higher potency compounds and adapt to the changing marketplace with soloVERSO™.
Make your manufacturing facility agile to customer demands as cleaning and validation are removed with this single-use, disposable solution. Increase your forecast of product runs by removing this stage of the turnaround process. Stay on track and remove the risk of undertaking costly and lengthy validations. soloVERSO™ can be supplied to a standardized design or customized to suit a wide range of applications in the pharmaceutical industry.
WHITE PAPERS AND CASE STUDIES
-
PV Solutions Optimizing End-To-End Safety In Clinical Development
Explore what the future of PV services and technology in the life sciences industry could look like if innovation, regulatory vigilance, and collaboration with regulatory bodies were prioritized.
-
8 Ways To Achieve Higher ROI In Quality
Is your company still using outdated methods for its QMS? It's time to evolve. Discover how an integrated QMS can streamline operations, enhance compliance, and support your company's growth and innovation.
-
Improving API Solubility
Ensuring adequate solubility is crucial for small molecule drugs' effectiveness. Find out how poor solubility remains a significant challenge, potentially hindering medications from reaching the market.
-
Using SerumSub™ QualAssure™ To Assess Liquid Transfer Performance
In this study, SerumSub™ QualAssure™, a serum-like reference solution with liquid handling properties that are analogous to several commonly used sera, is compared to various commercially available mammalian sera.
-
Designing, Selecting, And Developing Bioconjugates For Clinical Success
Accelerate the development of complex bioconjugates to unlock new possibilities for targeted therapies and advance the next generation of precision medicine.
-
RO Membranes' Protection At Pinghu Power Plant, China
A power plant in Pinghu, Zhejiang Province in China needed to replace the use of chemical biocides and protect boiler feed make-up water from anaerobic and aerobic bacterial growth and associated biofouling.
-
Compliance Auditing: Diving Into Common Critical Findings
Review critical findings in compliance audits, highlighting frequent issues, their impact on operations, and steps companies can take to improve regulatory compliance.
-
Eliminating USP <88> In Vivo Animal Bioreactivity Testing For Polymer Characterization
There has been growing awareness about the environmental and ethical implications of plastics used in bioprocessing. The time for a shift to well-studied, proven in vitro cytotoxicity testing is now.
-
Prioritize Process Validation To Mitigate Manufacturing Risks
Medical device manufacturers must prioritize process validation to ensure safe and effective performance. Neglecting this can lead to severe consequences. This article covers essential elements of process validation due diligence.
-
What Is A "Smart" Amplifier?
Recent advancements in amplifier design provide substantial improvements in terms of both flexibility and efficiency, creating a new class of "smart amplifiers."
-
Molecular Properties Of PROTACs And The Relationship To Formulation Design
Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
-
Optimized Fill And Finish To Limit DMSO's Negative Impact On T Cells
In order to improve the existing cryopreservation paradigm, operators must consider fill/finish and cryopreservation techniques that streamline processing steps and minimize cells’ exposure to DMSO.
NEWS
-
CamScanner Launches Magic Pro Filter To Make Scanned Documents Perfect With Just One Click2/22/2024
CamScanner, a global leader in document scanning apps with over 300 million users, recently unveiled a revolutionary new tool enabling users to make their scanned documents perfectly clear with just one click. The cutting-edge "Magic Pro Filter" feature, powered by artificial intelligence, automatically detects blurs, and shadows in scans and effortlessly removes them.
-
Verizon To Acquire Frontier9/5/2024
Verizon Communications Inc. (NYSE, NASDAQ: VZ) and Frontier Communications Parent, Inc. (NASDAQ: FYBR) today announced they have entered into a definitive agreement for Verizon to acquire Frontier in an all-cash transaction valued at $20 billion.
-
TOMI Environmental Solutions Secures Contract With Malaysian Government For SteraMist Technology, Strengthening Global Market Position10/24/2024
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it has secured a contract with the National Institute of Forensic Medicine (IPFN) in Malaysia.
-
TX RX Systems, Inc. Redefines Connectivity Standards With Class A And Class B 700/800 MHz Bi-Directional Amplifiers (BDAs)1/12/2024
TX RX Systems, Inc., the market leader in radio frequency (RF) design and engineering, continues to redefine standards in signal enhancements with its Class A and Class B 700/800 bi-directional amplifiers (BDAs) to provide unparalleled intelligence, reliability and adaptability for a diverse range of applications.
-
Novotech Honored With Frost & Sullivan's 2024 Best Practices Company Of The Year Award For Leadership In Biotech CRO Services9/10/2024
Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan. This recognition underscores Novotech’s commitment to accelerating clinical development for biotech companies through innovative solutions, advanced analytics, and a comprehensive global reach.